BioCentury
ARTICLE | Company News

Acambis gains on smallpox contract

November 29, 2001 8:00 AM UTC

Acambis (LSE:ACM; ACAM) was up 71.5p (29%) to 314.5p on Thursday. The company announced post-market on Wednesday the receipt of a $428 million contract from the U.S. Centers for Disease Control and Pr...